ROIV
Price:
$11.995
Market Cap:
$8.73B
Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne, myasthenia gravis, warm autoimmune hemolytic anemia, thyroid eye diseases, sarcoidosis, and staph aureus bacteremia. The company was founded in 2014 and is based in London, the United Kingdom.[Read more]
Industry
Biotechnology
IPO Date
2020-12-08
Stock Exchange
NASDAQ
Ticker
ROIV
According to Roivant Sciences Ltd.’s latest financial reports and current stock price. The company's current Current Ratio is 10.43. This represents a change of -54.34% compared to the average of 22.84 of the last 4 quarters.
The mean historical Current Ratio of Roivant Sciences Ltd. over the last ten years is 15.51. The current 10.43 Current Ratio has changed 6.62% with respect to the historical average. Over the past ten years (40 quarters), ROIV's Current Ratio was at its highest in in the June 2024 quarter at 27.91. The Current Ratio was at its lowest in in the September 2023 quarter at 5.84.
Average
15.51
Median
11.64
Minimum
6.60
Maximum
25.24
Discovering the peaks and valleys of Roivant Sciences Ltd. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 282.27%
Maximum Annual Current Ratio = 25.24
Minimum Annual Increase = -58.54%
Minimum Annual Current Ratio = 6.60
Year | Current Ratio | Change |
---|---|---|
2024 | 25.24 | 282.27% |
2023 | 6.60 | -43.30% |
2022 | 11.64 | 16.57% |
2021 | 9.99 | -58.54% |
The current Current Ratio of Roivant Sciences Ltd. (ROIV) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
14.49
5-year avg
15.51
10-year avg
15.51
Roivant Sciences Ltd.’s Current Ratio is less than Krystal Biotech, Inc. (0), greater than Prometheus Biosciences, Inc. (7.97), less than Akero Therapeutics, Inc. (31.04), less than Apellis Pharmaceuticals, Inc. (17.25), greater than Day One Biopharmaceuticals, Inc. (4.36), less than Phathom Pharmaceuticals, Inc. (14.62), greater than Blueprint Medicines Corporation (5.73), greater than Lyra Therapeutics, Inc. (3.32), greater than Cullinan Oncology, Inc. (3.64), less than Ascendis Pharma A/S (24.46), greater than BeiGene, Ltd. (1.16), greater than Pliant Therapeutics, Inc. (1.93), greater than Syndax Pharmaceuticals, Inc. (10.26), greater than Revolution Medicines, Inc. (6.99), less than Viridian Therapeutics, Inc. (14.24), less than Inozyme Pharma, Inc. (18.55), greater than null (7.68),
Company | Current Ratio | Market cap |
---|---|---|
0 | $4.53B | |
7.97 | $9.56B | |
31.04 | $1.98B | |
17.25 | $4.11B | |
4.36 | $1.28B | |
14.62 | $507.36M | |
5.73 | $5.71B | |
3.32 | $11.35M | |
3.64 | $713.29M | |
24.46 | $8.34B | |
1.16 | $20.01B | |
1.93 | $808.14M | |
10.26 | $1.12B | |
6.99 | $8.06B | |
14.24 | $1.52B | |
18.55 | $189.19M | |
7.68 | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Roivant Sciences Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Roivant Sciences Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Roivant Sciences Ltd.'s Current Ratio?
How is the Current Ratio calculated for Roivant Sciences Ltd. (ROIV)?
What is the highest Current Ratio for Roivant Sciences Ltd. (ROIV)?
What is the 3-year average Current Ratio for Roivant Sciences Ltd. (ROIV)?
What is the 5-year average Current Ratio for Roivant Sciences Ltd. (ROIV)?
How does the current Current Ratio for Roivant Sciences Ltd. (ROIV) compare to its historical average?